Of @ patients with CNS metastases at baseline , @ ( @ % ) had an objective response ; six ( @ % ) had a complete response ( three unconfirmed ) and five ( @ % ) had a partial response ( one unconfirmed ) ; eight ( @ % ) patients had stable disease and the remaining two ( @ % ) had progressive disease .